You are receiving a personalized analytical report that goes beyond standard result interpretation. Your data has been processed by an advanced analytical system that performed a multi-level comparative analysis of complex biochemical patterns. What you see is not a simple opinion, but a data synthesis designed to identify subtle relationships and patterns that may be overlooked in traditional assessment. Treat this document as an advanced support tool providing deep insight into your pet's current biochemical state — taking into account its species, breed, age, and individual characteristics.
Creatinine is a waste product generated from the normal breakdown of muscle tissue. It is produced at a relatively constant rate and is primarily excreted by the kidneys. In cats, creatinine levels in the blood are used as a marker of renal function, as it is filtered out of the blood by the kidneys and excreted in urine. According to the WSAVA guidelines, creatinine is a key parameter in assessing kidney health, and its levels can indicate how well the kidneys are functioning. In healthy cats, creatinine levels remain stable, reflecting a balance between muscle metabolism and renal excretion.
In this 13-year-old European Shorthair cat, the creatinine level is elevated at 2.6 mg/dL, which is above the laboratory reference range of 0.8-2.1 mg/dL. This indicates a significant deviation from normal renal function, suggesting impaired kidney filtration. Given the cat's age and history of chronic kidney disease (CKD) IRIS stage 1, this elevation is concerning and suggests progression of renal insufficiency. The increase in creatinine, coupled with the clinical signs of increased thirst, urination, weight loss, and lethargy, aligns with worsening renal function.
The elevated creatinine level in this cat is indicative of decreased kidney function, commonly associated with CKD. This is supported by the concurrent elevation of blood urea nitrogen (BUN) at 44 mg/dL and phosphate at 6.9 mg/dL, both of which are also above their respective reference ranges. The low potassium level at 3.4 mEq/L is consistent with renal disease, as cats with CKD often experience electrolyte imbalances. The anemia, as indicated by low hematocrit (29%), RBC (6.4 x10^6/uL), and hemoglobin (10.2 g/dL), may be a result of decreased erythropoietin production by the kidneys. The elevated liver enzymes (ALT, ALP, and GGT) and total bilirubin suggest possible concurrent hepatic involvement or secondary effects of systemic illness.
If the elevated creatinine level remains unaddressed, the cat's renal function is likely to continue deteriorating, leading to more severe azotemia, electrolyte imbalances, and potentially life-threatening complications such as uremic crisis. The progression of CKD can result in further weight loss, muscle wasting, and decreased quality of life. However, with appropriate management, including dietary modifications, phosphate binders, and potentially fluid therapy, the progression of renal disease can be slowed, improving the cat's prognosis and quality of life. Early intervention and regular monitoring are crucial in managing CKD in cats, particularly given the advanced age and current clinical signs of this patient.
Blood urea nitrogen (BUN) is a measure of the concentration of nitrogen in the blood in the form of urea, which is a waste product formed in the liver from the breakdown of proteins. In cats, as obligate carnivores, protein metabolism is a significant physiological process, and the urea cycle is crucial for the excretion of excess nitrogen. BUN levels are regulated by the kidneys, which filter urea out of the blood and excrete it in urine. According to the WSAVA guidelines, BUN is a key indicator of renal function, as well as protein metabolism and liver function. Elevated BUN levels can indicate impaired kidney function, increased protein catabolism, or dehydration, among other conditions. In this 13-year-old spayed female European Shorthair cat, the BUN level is elevated at 44 mg/dL, above the reference range of 17-35 mg/dL. This elevation suggests a deviation from normal renal function, which is consistent with the cat's history of chronic kidney disease (CKD) IRIS stage 1. The increase in BUN, alongside the elevated creatinine level of 2.6 mg/dL, indicates a progression of renal insufficiency. The concurrent high phosphate level of 6.9 mg/dL further supports the presence of renal dysfunction, as hyperphosphatemia is commonly associated with CKD in cats. Clinically, elevated BUN levels can be associated with conditions such as dehydration, high protein diets, gastrointestinal bleeding, and renal disease. In this case, the elevated BUN is likely due to the progression of CKD, as evidenced by the concurrent high creatinine and phosphate levels. The low potassium level of 3.4 mEq/L may indicate renal tubular acidosis or inadequate dietary intake, both of which can occur in CKD. The low hematocrit (29%) and low red blood cell count (6.4 x10^6/uL) suggest anemia, which is a common complication of CKD due to decreased erythropoietin production by the kidneys. If the elevated BUN and associated renal dysfunction are not addressed, the cat may experience worsening azotemia, leading to uremic symptoms such as vomiting, anorexia, and lethargy, as reported by the owner. Over time, this can result in significant deterioration of the cat's quality of life and potentially life-threatening complications. However, with appropriate management, including dietary modifications, phosphate binders, and potentially erythropoietin supplementation, the progression of CKD can be slowed, and the cat's quality of life can be improved. Regular monitoring of renal parameters and clinical signs is essential to adjust the treatment plan as needed.
Phosphate, also known as inorganic phosphorus, is a critical mineral in feline physiology, playing a vital role in bone formation, energy metabolism, and cellular signaling. It is a component of ATP, which is essential for energy transfer within cells. Phosphate levels are regulated by the kidneys, parathyroid hormone (PTH), and vitamin D. In cats, phosphate is absorbed from the diet and excreted primarily through the kidneys. The WSAVA guidelines emphasize the importance of monitoring phosphate levels, especially in cats with renal disease, as they are prone to hyperphosphatemia due to decreased renal excretion.
In this 13-year-old spayed female European Shorthair cat, the phosphate level is elevated at 6.9 mg/dL, exceeding the laboratory reference range of 2.6-5.5 mg/dL. This indicates hyperphosphatemia. Given the cat's age and history of chronic kidney disease (CKD), this elevation is significant. Hyperphosphatemia in CKD is often due to reduced renal clearance, as the kidneys lose their ability to excrete phosphate efficiently. The magnitude of this elevation suggests a progression of renal impairment, which is consistent with the reported symptoms of increased thirst, polyuria, weight loss, and lethargy.
Clinically, hyperphosphatemia in cats is often associated with CKD, as seen in this patient. It can lead to secondary hyperparathyroidism, which exacerbates renal damage and contributes to bone demineralization. The elevated creatinine (2.6 mg/dL) and BUN (44 mg/dL) further support the diagnosis of CKD, while the low potassium (3.4 mEq/L) may indicate renal tubular acidosis or inadequate dietary intake. The elevated ALT (165 U/L), ALP (68 U/L), and GGT (4 U/L) suggest concurrent hepatobiliary stress, which may be secondary to the metabolic derangements or an independent process. The low hematocrit (29%) and RBC count (6.4 x10^6/uL) indicate anemia, likely of chronic disease, which is common in CKD.
If the hyperphosphatemia remains unaddressed, this cat is at risk of further renal deterioration, leading to more severe azotemia and potential progression to IRIS stage 2 or higher CKD. This could occur over weeks to months, depending on the underlying cause and the cat's overall health. Addressing the hyperphosphatemia through dietary phosphate binders and renal diet modification can slow the progression of CKD and improve quality of life. If managed appropriately, the prognosis can be stabilized, with potential improvement in clinical signs such as appetite and energy levels. However, without intervention, the cat's condition is likely to worsen, leading to increased morbidity and a decreased lifespan.
Calcium plays a crucial role in various physiological processes in cats, including bone health, muscle function, nerve transmission, and blood coagulation. It is essential for maintaining the structural integrity of bones and teeth, as well as facilitating normal cellular functions and signaling pathways throughout the body. Proper calcium levels are vital for overall health and well-being, especially in older cats who may be more susceptible to metabolic changes and diseases affecting their organ systems.
The calcium level for your cat is 10.6 mg/dL, which falls within the normal reference range of 9.0-11.3 mg/dL. This indicates that her calcium metabolism is functioning appropriately at this time. Given her age of 13 years and the reported symptoms, including increased thirst and urination, weight loss, and vomiting, it is reassuring that her calcium level is normal. This suggests that there are no immediate concerns related to calcium imbalances, which can sometimes be associated with conditions like chronic kidney disease or certain cancers. However, continued monitoring and further evaluation of her other symptoms are important for her overall health management.
Potassium is a vital electrolyte in cats, playing a crucial role in maintaining cellular function, nerve impulse transmission, and muscle contraction. It is primarily regulated by the kidneys, which excrete excess potassium to maintain homeostasis. Potassium levels are influenced by dietary intake, renal function, and hormonal regulation, particularly by aldosterone. In cats, maintaining appropriate potassium levels is essential for normal neuromuscular and cardiac function, as outlined in the WSAVA guidelines.
In this 13-year-old spayed female European Shorthair, the potassium level is 3.4 mEq/L, which is below the laboratory's reference range of 3.8-5.5 mEq/L, indicating hypokalemia. This deviation is mild but noteworthy, especially given the patient's history of chronic kidney disease (CKD) and current symptoms such as increased thirst, weight loss, and lethargy. Hypokalemia in cats can exacerbate muscle weakness and contribute to the overall clinical picture of malaise and reduced activity.
Hypokalemia in cats is often associated with renal disease, as impaired kidney function can lead to increased potassium loss. The elevated creatinine (2.6 mg/dL) and BUN (44 mg/dL) levels support the presence of renal insufficiency, which is likely contributing to the low potassium level. Additionally, the low potassium level may be related to the cat's reduced appetite and vomiting, as gastrointestinal losses can also lead to hypokalemia. The concurrent low albumin (3.1 g/dL) and high phosphate (6.9 mg/dL) levels further suggest a complex interplay of renal and nutritional factors affecting electrolyte balance.
If the hypokalemia remains unaddressed, the cat may experience worsening muscle weakness, lethargy, and potentially cardiac arrhythmias over time. Addressing the underlying renal dysfunction and ensuring adequate dietary potassium intake could stabilize the potassium level, improving the cat's overall condition and quality of life. Managing the CKD and monitoring electrolyte levels will be crucial in preventing further complications and maintaining the cat's health. Early intervention can improve prognosis by preventing progression to more severe clinical signs and maintaining better renal function.
Sodium plays a crucial role in maintaining fluid balance, nerve function, and muscle contractions in cats. It is an essential electrolyte that helps regulate blood pressure and is involved in the transport of nutrients and waste products across cell membranes. Proper sodium levels are vital for overall health, particularly in older cats, who may be more susceptible to imbalances due to age-related changes in kidney function and other physiological processes.
The sodium level for your cat is 152 mEq/L, which falls within the normal reference range of 149-158 mEq/L. This indicates that her sodium balance is currently stable, which is a positive sign given her age and the symptoms you have reported, such as increased thirst and urination. Maintaining normal sodium levels is important, especially in a senior cat with chronic kidney disease, as it suggests that her electrolyte status is being managed effectively despite her other health challenges.
Chloride plays a crucial role in maintaining the body's acid-base balance and fluid regulation in cats. It is an essential electrolyte that helps to control osmotic pressure and is involved in the production of gastric acid, which is important for digestion. Proper chloride levels are vital for normal cellular function and overall metabolic processes, especially in a feline's unique physiology as an obligate carnivore.
Alanine aminotransferase (ALT) is an enzyme primarily found in the liver, with smaller amounts present in the kidneys and heart. It plays a crucial role in amino acid metabolism by catalyzing the transfer of an amino group from alanine to alpha-ketoglutarate, forming pyruvate and glutamate. In cats, ALT is a sensitive indicator of hepatocellular injury, as it is released into the bloodstream when liver cells are damaged. The WSAVA guidelines emphasize the importance of ALT in assessing liver health, particularly in obligate carnivores like cats, where liver function is critical for processing dietary proteins and fats efficiently.
In this 13-year-old spayed female European Shorthair, the ALT level is elevated at 165 U/L, exceeding the laboratory's reference range of 28-109 U/L. This elevation indicates hepatocellular damage or stress. Given the patient's age and chronic kidney disease history, this finding is significant. The increase in ALT, coupled with the clinical signs of weight loss, vomiting, and dull coat, suggests a possible underlying liver condition, which may be exacerbated by the existing renal issues.
Elevated ALT levels in cats can be associated with various conditions, including hepatic lipidosis, cholangitis, or neoplasia. The concurrent elevation of ALP at 68 U/L and GGT at 4 U/L, both above their respective reference ranges, supports the possibility of hepatobiliary disease. The high total bilirubin level of 0.2 mg/dL further indicates potential liver dysfunction or bile duct obstruction. The low potassium level at 3.4 mEq/L, alongside the elevated BUN and creatinine, suggests a renal component, possibly contributing to the electrolyte imbalance and further stressing the liver.
If the elevated ALT remains unaddressed, the patient may experience progressive liver damage, potentially leading to hepatic failure. This could manifest as worsening anorexia, jaundice, and further weight loss. However, if the underlying cause is identified and managed, such as through dietary adjustments or addressing potential hepatic lipidosis, the prognosis could improve significantly. The liver has a remarkable capacity for regeneration, and with appropriate intervention, the cat's liver function may stabilize, improving overall health and quality of life.
Alkaline phosphatase (ALP) is an enzyme found in various tissues throughout the body, including the liver, bone, kidney, and intestine. In cats, ALP is primarily associated with the liver and biliary system. It plays a crucial role in the process of dephosphorylation, which is important for various metabolic pathways. The enzyme is produced by the liver cells and is released into the bloodstream when there is increased production or when there is damage to the liver or bile ducts. In cats, even a mild elevation in ALP is considered clinically significant due to its short half-life, approximately 6 hours, compared to dogs. According to the WSAVA guidelines, ALP elevation should be carefully evaluated in the context of other liver enzymes and clinical signs.
In this 13-year-old spayed female European Shorthair cat, the ALP level is elevated at 68 U/L, above the reference range of 11-49 U/L. This elevation is significant given the short half-life of ALP in cats and suggests a potential hepatobiliary issue. The elevation is moderate and should be interpreted in conjunction with other clinical findings and laboratory results. The cat's age and breed do not specifically predispose it to conditions that would cause ALP elevation, but the age-related increase in the likelihood of liver or biliary disease should be considered.
The clinical implications of an elevated ALP in this cat include potential liver disease, cholestasis, or biliary obstruction. The concurrent elevation of ALT at 165 U/L and GGT at 4 U/L supports the suspicion of hepatobiliary disease, as GGT is more specific for biliary issues in cats. The high total bilirubin of 0.2 mg/dL further suggests possible cholestasis or liver dysfunction. The low albumin level at 3.1 g/dL may indicate chronic liver disease or protein loss. The elevated BUN at 44 mg/dL and creatinine at 2.6 mg/dL, along with the history of chronic kidney disease, suggest renal involvement, which can complicate the interpretation of liver enzyme elevations. The low potassium level at 3.4 mEq/L could be related to renal issues or secondary to vomiting and anorexia.
If the underlying cause of the elevated ALP is not addressed, this cat may experience progressive liver dysfunction, leading to worsening clinical signs such as jaundice, anorexia, and lethargy. Over time, untreated liver disease can result in hepatic failure, which is life-threatening. However, if the cause is identified and managed appropriately, such as through dietary changes, medication, or addressing any biliary obstruction, the prognosis can improve significantly. Early intervention is crucial to prevent irreversible liver damage and to improve the quality of life for this cat. Maintaining ALP within the normal range is important for the long-term health of a senior cat, as it indicates stable liver function and overall metabolic health.
Gamma-glutamyl transferase (GGT) is an enzyme primarily associated with the liver and biliary system in cats. It plays a crucial role in the transfer of amino acids and peptides across the cellular membrane and is involved in glutathione metabolism. GGT is predominantly found in the liver, kidney, and pancreas, with its activity being highest in the bile ducts. In cats, GGT is a more specific marker for hepatobiliary disease than alkaline phosphatase (ALP), as cats do not produce significant amounts of ALP from bone. According to the WSAVA guidelines, GGT is often used in conjunction with other liver enzymes to assess liver function and biliary obstruction.
In this 13-year-old spayed female European Shorthair cat, the GGT level is elevated at 4 U/L, exceeding the laboratory's reference range of 0-2 U/L. This elevation indicates a potential hepatobiliary issue, which is significant given the cat's age and clinical presentation. The increase in GGT, although mild, should not be overlooked, especially in cats where even slight elevations can be clinically relevant due to the enzyme's short half-life.
The elevated GGT in this cat suggests possible cholestasis or hepatocellular damage. This is supported by concurrent elevations in ALT at 165 U/L and ALP at 68 U/L, both of which are above their respective reference ranges. The high total bilirubin level of 0.2 mg/dL further supports the presence of liver dysfunction. The low albumin level at 3.1 g/dL and high globulin level at 5.2 g/dL may indicate chronic liver disease or inflammation. The presence of chronic kidney disease, as indicated by elevated creatinine at 2.6 mg/dL and BUN at 44 mg/dL, could also contribute to the overall clinical picture, as renal and hepatic functions are often interrelated.
If the underlying cause of the elevated GGT is not addressed, this cat may experience progressive liver dysfunction, potentially leading to hepatic failure. Over time, this could exacerbate the clinical signs of weight loss, anorexia, and lethargy. However, if the cause is identified and managed appropriately, such as addressing potential hepatobiliary obstruction or inflammation, the prognosis can be significantly improved. Early intervention may stabilize liver function and improve the cat's quality of life, reducing symptoms like vomiting and dull coat condition. Given the cat's age and existing chronic kidney disease, a comprehensive approach to management is essential for optimal outcomes.
Total bilirubin is a measure of the bilirubin concentration in the blood, which is a byproduct of the normal breakdown of red blood cells. In cats, bilirubin is processed by the liver, where it is conjugated and then excreted into the bile. This process is crucial for the elimination of waste products from the body. The WSAVA guidelines emphasize the importance of liver function in maintaining normal bilirubin levels, as any disruption in liver function can lead to an accumulation of bilirubin in the blood, resulting in jaundice. In this patient, the total bilirubin level is 0.2 mg/dL, which is above the laboratory's reference range of 0-0.1 mg/dL, indicating hyperbilirubinemia. This elevation suggests a potential issue with bilirubin metabolism or excretion, possibly due to liver dysfunction or hemolysis. Given the patient's age and history of chronic kidney disease, it is important to consider the possibility of concurrent liver disease or hemolytic anemia. The clinical implications of elevated bilirubin in cats include liver disease, such as hepatic lipidosis or cholangitis, and hemolytic anemia. In this case, the elevated ALT at 165 U/L, ALP at 68 U/L, and GGT at 4 U/L support the possibility of hepatobiliary disease. The low albumin level at 3.1 g/dL and high globulin level at 5.2 g/dL may indicate chronic inflammation or liver dysfunction. The presence of anemia, with a low hematocrit of 29% and low RBC count of 6.4 x10^6/uL, could also contribute to the elevated bilirubin if hemolysis is occurring. If the underlying cause of the elevated bilirubin is not addressed, the patient may experience progressive liver damage, leading to further deterioration of liver function and potential development of hepatic encephalopathy. Over time, this could result in significant morbidity and a decline in quality of life. However, if the cause is identified and managed appropriately, such as through dietary modifications, supportive care, and specific treatments for liver disease or anemia, the prognosis can be improved. Maintaining bilirubin within the normal range is important for the long-term health of a senior cat, as it indicates effective liver function and the absence of significant hemolysis.
Glucose plays a crucial role in a cat's metabolism as it serves as a primary energy source for cells, particularly in the brain and muscles. Cats, being obligate carnivores, have unique metabolic pathways that prioritize protein and fat utilization, but glucose remains essential for various physiological processes, including maintaining normal brain function and overall energy levels. In healthy cats, glucose levels are tightly regulated by hormones such as insulin and glucagon, ensuring that the body has a steady supply of energy even during fasting periods or between meals.
Cholesterol plays a vital role in feline physiology, serving as a key component in cell membrane structure and function, as well as being a precursor for the synthesis of steroid hormones and bile acids. In cats, cholesterol levels can be influenced by various factors, including diet, metabolic health, and liver function, making it an important parameter to monitor, especially in senior cats or those with underlying health conditions.
Amylase is an enzyme produced primarily by the pancreas and plays a crucial role in the digestion of carbohydrates in cats. It helps break down starches into sugars, facilitating nutrient absorption. While amylase is present in other tissues, its primary function in the cat is linked to pancreatic activity, making it an important marker for assessing digestive health and pancreatic function.
The amylase value for your cat is 1420 U/L, which falls within the normal reference range of 603-2183 U/L. This indicates that her pancreatic function is likely normal, which is reassuring given her age and the symptoms she is experiencing, such as increased thirst, urination, and weight loss. While these symptoms can be concerning, the normal amylase level suggests that her digestive processes are functioning adequately at this time. It is important to continue monitoring her condition, especially considering her chronic kidney disease and the potential for other underlying issues.
Lipase is an enzyme produced primarily by the pancreas that plays a crucial role in the digestion of fats. In cats, lipase helps break down dietary fats into fatty acids and glycerol, which can then be absorbed and utilized by the body for energy and other metabolic processes. Monitoring lipase levels can provide valuable insights into pancreatic function and overall digestive health in felines.
Total protein in a cat's blood is a measure of the combined levels of albumin and globulin, which are critical components of the blood plasma. Albumin, produced by the liver, plays a vital role in maintaining oncotic pressure and transporting various substances, including hormones and drugs. Globulins, which include antibodies, are essential for immune function and are produced by the liver and the immune system. The balance and levels of these proteins are regulated by liver function, nutritional status, and the body's immune response. According to the WSAVA guidelines, maintaining appropriate protein levels is crucial for overall health and metabolic function in cats.
In this 13-year-old spayed female European Shorthair cat, the total protein level is elevated at 8.9 g/dL, exceeding the laboratory reference range of 6.6-8.4 g/dL. This elevation indicates hyperproteinemia, which is primarily due to an increase in globulin levels, as the albumin level is actually low at 3.1 g/dL. The increase in total protein is significant and suggests an underlying chronic inflammatory or infectious process, given the concurrent elevation in globulin. The age and breed of the cat, along with her chronic kidney disease history, are important considerations in interpreting this result.
Elevated total protein levels in cats can be associated with chronic inflammation, infection, or neoplasia. The concurrent low albumin level suggests a possible protein-losing nephropathy or liver dysfunction, which aligns with the elevated creatinine (2.6 mg/dL) and BUN (44 mg/dL), indicating renal involvement. The elevated ALT (165 U/L), ALP (68 U/L), and GGT (4 U/L) suggest liver stress or damage, which could contribute to altered protein synthesis. The high phosphate level (6.9 mg/dL) and low potassium (3.4 mEq/L) further support renal compromise. The anemia, indicated by low HCT (29%), RBC (6.4 x10^6/uL), and hemoglobin (10.2 g/dL), may be due to chronic disease or renal insufficiency, which can also affect protein levels.
If the underlying cause of this hyperproteinemia is not addressed, the cat may experience worsening renal function, further liver compromise, and potential progression to more severe systemic illness. Chronic kidney disease could advance to a higher IRIS stage, leading to more pronounced symptoms and a decline in quality of life. However, if the cause is identified and managed, such as through dietary adjustments, medication to support kidney and liver function, and addressing any underlying infections or inflammatory conditions, the prognosis can improve. Stabilizing protein levels and managing the associated conditions can help maintain the cat's health and potentially extend her lifespan, considering her age and current health status.
Albumin is a crucial protein synthesized by the liver, playing a vital role in maintaining oncotic pressure, which helps keep fluid within the blood vessels. It also serves as a carrier protein for various substances, including hormones, vitamins, and drugs. In cats, albumin levels are regulated by liver function, nutritional status, and the body's overall protein metabolism. According to the WSAVA Global Nutrition Guidelines, maintaining adequate protein intake is essential for cats, especially given their obligate carnivorous nature. Albumin levels can be influenced by liver health, kidney function, and nutritional intake.
In this 13-year-old spayed female European Shorthair cat, the albumin level is slightly below the reference range at 3.1 g/dL, with the laboratory range being 3.2-4.3 g/dL. This indicates a mild hypoalbuminemia. Given the patient's age and chronic kidney disease (CKD) history, this decrease could be significant, as albumin levels often reflect the cat's nutritional and health status. The low albumin level, although only slightly below the reference range, should be considered in the context of the cat's overall clinical picture, including weight loss, decreased appetite, and increased drinking and urination.
Hypoalbuminemia in cats can be associated with several conditions, including liver disease, protein-losing nephropathy, or gastrointestinal disease. In this case, the elevated creatinine at 2.6 mg/dL and BUN at 44 mg/dL, along with the history of CKD, suggest that renal protein loss could be contributing to the low albumin level. The elevated ALT at 165 U/L, ALP at 68 U/L, and GGT at 4 U/L indicate potential liver involvement, which could also affect albumin production. The low potassium level at 3.4 mEq/L and the presence of anemia, with a hematocrit of 29%, further support the possibility of a systemic condition affecting multiple organ systems.
If the hypoalbuminemia remains unaddressed, the cat may experience worsening edema or ascites due to decreased oncotic pressure, further weight loss, and potential progression of underlying renal or hepatic disease. The prognosis depends on identifying and managing the underlying cause. If the cause is related to CKD, appropriate management, including dietary modifications and potential medication, could stabilize the albumin levels and improve the cat's overall health. Addressing any liver dysfunction with supportive care and monitoring could also help improve albumin levels and the cat's clinical condition. Early intervention is crucial to prevent further deterioration and improve the quality of life for this senior cat.
Globulin is a group of proteins in the blood that play various roles, including immune function, transport of substances, and blood clotting. In cats, globulins are produced primarily by the liver and the immune system. They are divided into alpha, beta, and gamma globulins, each with specific functions. Alpha and beta globulins are mainly transport proteins and enzymes, while gamma globulins are immunoglobulins, which are critical for immune response. The balance and levels of these proteins are crucial for maintaining health, as they help in fighting infections and carrying essential substances throughout the body. According to the WSAVA guidelines, monitoring globulin levels can provide insights into the immune status and potential inflammatory or neoplastic conditions in cats.
In this 13-year-old spayed female European Shorthair cat, the globulin level is elevated at 5.2 g/dL, exceeding the laboratory's reference range of 2.9-4.7 g/dL. This indicates hyperglobulinemia, which is a significant finding. Given the patient's age and clinical presentation, this elevation could be associated with chronic inflammatory conditions, immune-mediated diseases, or neoplastic processes. The increase in globulin levels, coupled with the clinical signs of weight loss, increased thirst and urination, and dull coat, suggests a systemic issue that requires further investigation.
Elevated globulin levels in cats can be associated with chronic infections, such as feline infectious peritonitis (FIP), or immune-mediated diseases like systemic lupus erythematosus. Neoplastic conditions, such as multiple myeloma or lymphoma, can also cause hyperglobulinemia. In this patient, the concurrent abnormalities in other parameters, such as elevated creatinine (2.6 mg/dL), BUN (44 mg/dL), and phosphate (6.9 mg/dL), suggest renal involvement, possibly exacerbated by dehydration or underlying renal disease. The low albumin level (3.1 g/dL) and anemia (HCT 29%, RBC 6.4 x10^6/uL, hemoglobin 10.2 g/dL) further support the possibility of a chronic inflammatory or neoplastic process. The elevated liver enzymes (ALT 165 U/L, ALP 68 U/L, GGT 4 U/L) and total bilirubin (0.2 mg/dL) suggest concurrent liver involvement, which could be secondary to the primary disease process or due to hepatic lipidosis, especially given the history of weight loss and anorexia.
If the underlying cause of the hyperglobulinemia is not addressed, the patient may experience progressive deterioration of renal and hepatic function, leading to more severe clinical signs and potentially life-threatening complications. Over time, chronic inflammation or neoplastic processes can lead to further organ damage, exacerbating the patient's clinical condition. However, if the cause is identified and managed appropriately, such as through targeted therapy for an underlying infection or immune-mediated condition, the prognosis can improve significantly. Early intervention may stabilize the patient's condition, improve quality of life, and potentially extend survival. For a cat of this age and breed, maintaining globulin levels within the normal range is crucial for long-term health, as it supports immune function and overall systemic balance.
Hematocrit (HCT) is a measure of the proportion of blood volume that is occupied by red blood cells (RBCs). It is a critical parameter in assessing the oxygen-carrying capacity of the blood, as RBCs are responsible for transporting oxygen from the lungs to tissues throughout the body. In cats, as obligate carnivores, maintaining adequate oxygen delivery is essential for their high metabolic rate and energy demands. The production and regulation of RBCs, and thus HCT, are primarily controlled by erythropoietin, a hormone produced by the kidneys in response to hypoxia. The WSAVA guidelines emphasize the importance of monitoring HCT in conjunction with other parameters to assess overall health and detect potential anemia or polycythemia early.
In this 13-year-old spayed female European Shorthair cat, the HCT is 29%, which is below the laboratory reference range of 31-48%. This indicates a mild anemia. Given the cat's age and chronic kidney disease (CKD) history, this finding is not unexpected, as CKD can lead to decreased erythropoietin production and subsequent anemia. The low HCT is consistent with the clinical signs reported by the owner, such as lethargy and reduced activity, which can be attributed to decreased oxygen delivery to tissues.
The clinical implications of a low HCT in this cat include potential chronic kidney disease progression, as evidenced by elevated creatinine at 2.6 mg/dL and BUN at 44 mg/dL. The low potassium level at 3.4 mEq/L may also contribute to muscle weakness and lethargy. The anemia is likely non-regenerative, given the low reticulocyte percentage of 0.1%, and is compounded by the low RBC count of 6.4 x10^6/uL and low hemoglobin of 10.2 g/dL. The elevated phosphate level at 6.9 mg/dL further suggests renal compromise. The concurrent liver enzyme elevations (ALT, ALP, GGT) and total bilirubin may indicate hepatic involvement or secondary effects of systemic illness, such as hepatic lipidosis, which can occur rapidly in cats with anorexia.
If the underlying cause of the anemia, likely related to CKD, is not addressed, the cat may experience worsening clinical signs, including increased lethargy, weakness, and potentially further weight loss. Over time, untreated anemia can lead to significant morbidity due to inadequate tissue oxygenation. However, if the anemia is managed through interventions such as erythropoietin supplementation or addressing the CKD progression, the cat's quality of life can improve, with increased energy levels and reduced clinical signs. Early intervention is crucial to prevent further deterioration and to maintain the cat's health and well-being.
Red blood cells (RBCs) are crucial for transporting oxygen from the lungs to tissues throughout the body and returning carbon dioxide from tissues to the lungs for exhalation. In cats, RBCs are produced in the bone marrow under the stimulation of erythropoietin, a hormone primarily produced by the kidneys. The lifespan of feline RBCs is approximately 70 days, and their production is tightly regulated to maintain adequate oxygen delivery to tissues. The WSAVA Feline Life Stage Guidelines emphasize the importance of monitoring RBC levels, especially in senior cats, as they are prone to various conditions that can affect erythropoiesis or RBC survival.
In this 13-year-old spayed female European Shorthair cat, the RBC count is 6.4 x10^6/uL, which is below the laboratory reference range of 6.9-10.1 x10^6/uL. This indicates a mild anemia. Given the patient's age and chronic kidney disease (CKD) history, this finding is not unexpected, as CKD can lead to decreased erythropoietin production, resulting in reduced RBC production. The anemia is further supported by low hematocrit (29%) and hemoglobin (10.2 g/dL) levels, both of which are also below their respective reference ranges.
The clinical implications of this anemia are significant. Anemia in cats can result from decreased RBC production, increased RBC destruction, or blood loss. In this case, the anemia is likely due to decreased production secondary to CKD. The low potassium level (3.4 mEq/L) may exacerbate the anemia by affecting muscle function and overall cellular metabolism. The elevated creatinine (2.6 mg/dL) and BUN (44 mg/dL) levels indicate renal insufficiency, which supports the hypothesis of reduced erythropoietin production. Additionally, the elevated phosphate (6.9 mg/dL) and low albumin (3.1 g/dL) levels suggest a chronic disease process, which can contribute to anemia of chronic disease.
If the underlying cause of the anemia, likely related to CKD, is not addressed, the patient may experience progressive weakness, lethargy, and decreased quality of life. Over time, untreated anemia can lead to compensatory mechanisms such as increased heart rate and cardiac output, potentially resulting in cardiac stress. However, if the anemia is managed through treatments such as erythropoietin supplementation or addressing the CKD more aggressively, the patient's RBC levels could stabilize, improving oxygen delivery and overall well-being. Early intervention is crucial to prevent further deterioration and to maintain the cat's quality of life.
Hemoglobin is a crucial protein found in red blood cells, responsible for transporting oxygen from the lungs to the tissues and facilitating the return of carbon dioxide from the tissues to the lungs for exhalation. In cats, as in other mammals, hemoglobin is synthesized in the bone marrow during erythropoiesis, a process regulated by erythropoietin, primarily produced by the kidneys. The function of hemoglobin is vital for maintaining cellular respiration and energy production, which are essential for the overall metabolic processes in the body. According to the WSAVA guidelines, maintaining adequate hemoglobin levels is critical for ensuring sufficient oxygen delivery to tissues, which is particularly important in obligate carnivores like cats, who have high protein and energy demands.
In this 13-year-old spayed female European Shorthair cat, the hemoglobin level is 10.2 g/dL, which is below the laboratory reference range of 10.9-15.7 g/dL, indicating anemia. This mild decrease in hemoglobin suggests a reduction in the oxygen-carrying capacity of the blood. Given the patient's age and history of chronic kidney disease (CKD), this finding is consistent with anemia of chronic disease, which is common in cats with CKD due to decreased erythropoietin production and potential blood loss or nutritional deficiencies.
The clinical implications of this low hemoglobin level include potential hypoxia, which may contribute to the lethargy and decreased activity reported by the owner. Anemia in cats can result from various conditions, including chronic kidney disease, inflammatory diseases, or nutritional deficiencies. In this case, the concurrent findings of elevated creatinine at 2.6 mg/dL and BUN at 44 mg/dL, along with low potassium at 3.4 mEq/L, support the diagnosis of CKD, which is likely contributing to the anemia. The low albumin level at 3.1 g/dL and high globulin level at 5.2 g/dL may also indicate a chronic inflammatory state, further supporting the anemia of chronic disease.
If the anemia remains unaddressed, the cat may experience progressive fatigue, decreased quality of life, and potential exacerbation of CKD symptoms due to reduced oxygen delivery to tissues. Over time, this could lead to further weight loss and muscle wasting. However, if the underlying cause, such as CKD, is managed effectively with appropriate interventions like erythropoietin supplementation and dietary adjustments, the anemia can be alleviated, improving the cat's energy levels and overall well-being. Early intervention is crucial to prevent further deterioration and to maintain the cat's quality of life.
Mean corpuscular volume (MCV) is a measure of the average size of red blood cells in a cat's bloodstream. It plays a crucial role in assessing the overall health of the blood and can provide insights into various conditions affecting red blood cell production and function. In cats, MCV can help differentiate between types of anemia and other hematological disorders, which is vital for diagnosing underlying health issues.
The MCV value for your cat is 45 fL, which falls within the normal reference range of 40-52 fL. This indicates that her red blood cells are of normal size, suggesting that there is no current evidence of anemia or other significant blood disorders. Given her age of 13 years and the reported symptoms, including increased thirst and urination, weight loss, and vomiting, it is reassuring that this parameter is normal, as it helps rule out certain hematological issues while you continue to monitor her overall health and manage her chronic kidney disease.
Mean corpuscular hemoglobin (MCH) is a measure of the average amount of hemoglobin contained in a single red blood cell. Hemoglobin is crucial for transporting oxygen throughout the body, which is essential for maintaining the overall health and energy levels of your cat. In cats, MCH helps to assess the oxygen-carrying capacity of the blood and can provide insights into various health conditions, including anemia or other blood disorders.
The MCH value for your cat is 16 pg, which falls within the normal reference range of 13-17 pg. This indicates that her red blood cells are adequately saturated with hemoglobin, suggesting that her oxygen transport capacity is normal at this time. Given her age of 13 years and the symptoms you've reported, such as increased thirst and urination, weight loss, and vomiting, it is reassuring that this specific parameter is within normal limits. However, it is important to continue monitoring her overall health, especially considering her chronic kidney disease and other symptoms.
The mean corpuscular hemoglobin concentration (MCHC) is a measure of the average concentration of hemoglobin in a given volume of packed red blood cells. In cats, this parameter is crucial for assessing the oxygen-carrying capacity of the blood, as hemoglobin is the protein responsible for transporting oxygen from the lungs to the tissues. A normal MCHC indicates that the red blood cells are adequately saturated with hemoglobin, which is essential for maintaining proper metabolic function and overall health in your cat.
The MCHC value for your cat is 34 g/dL, which falls within the normal reference range of 32-35 g/dL. This suggests that her red blood cells are functioning properly in terms of hemoglobin concentration, which is reassuring given her age and the reported symptoms of increased thirst, urination, and weight loss. While these symptoms may indicate underlying health issues, the normal MCHC value suggests that her anemia is not a concern at this time, allowing for further investigation into her other symptoms without the complication of a blood disorder.
White blood cells (WBC) play a crucial role in a cat's immune system, helping to defend against infections and diseases. They are essential for identifying and responding to pathogens, such as bacteria and viruses, and are involved in the inflammatory response. A healthy balance of white blood cells is vital for maintaining overall health and responding effectively to any potential threats to the body.
The WBC value for your cat is 14.8 x10^3/uL, which falls within the normal reference range of 5.1-16.2 x10^3/uL. This indicates that her immune system is functioning adequately at this time, which is reassuring given her age of 13 years and the reported symptoms of increased thirst, urination, and weight loss. While these symptoms may suggest underlying health issues, the normal WBC count suggests that there is currently no acute infection or significant immune response occurring, allowing for further evaluation of her condition without immediate concern for her immune status.
Neutrophils are a type of white blood cell that play a crucial role in the immune response of cats. They are primarily responsible for fighting off infections and responding to inflammation, acting as the first line of defense against pathogens. In healthy cats, neutrophils help to maintain the balance of the immune system, ensuring that the body can effectively respond to various challenges, including bacterial infections and tissue damage.
Lymphocytes are a type of white blood cell that play a crucial role in the immune system of cats. They are responsible for identifying and responding to pathogens, such as viruses and bacteria, and are essential for maintaining the body's defense mechanisms. A healthy balance of lymphocytes is important for a cat's overall health, especially as they age and may face various health challenges.
Monocytes play a crucial role in the immune system of cats, acting as a type of white blood cell that helps to fight infections and respond to inflammation. They are involved in the process of phagocytosis, where they engulf and digest pathogens and debris, and they also contribute to the regulation of immune responses. In healthy cats, monocyte levels can fluctuate based on various factors, including stress and overall health status, reflecting the body's response to potential threats or challenges.
Eosinophils are a type of white blood cell that play a crucial role in the immune response of cats, particularly in combating parasitic infections and mediating allergic reactions. They are involved in the inflammatory process and help regulate various immune functions, making them important for maintaining overall health and responding to certain diseases. In cats, eosinophils can also indicate the presence of allergies or other immune-related conditions when present in elevated numbers.
Basophils are a type of white blood cell that play a role in the immune response, particularly in allergic reactions and inflammation. They release histamine and other chemicals that help to mediate the body's response to allergens and parasites, contributing to the overall defense mechanisms of the cat's body. Although they are present in low numbers, their function is important for maintaining a healthy immune system.
Platelets, also known as thrombocytes, are small blood cells that play a crucial role in hemostasis, the process that stops bleeding by forming clots. In cats, as in other mammals, platelets are produced in the bone marrow from megakaryocytes and released into the bloodstream. They circulate for about 5-9 days before being removed by the spleen. Platelets are essential for wound healing and maintaining vascular integrity. According to WSAVA guidelines, platelet function and count are critical for assessing bleeding disorders and overall hemostatic balance in cats.
In this 13-year-old spayed female European Shorthair cat, the platelet count is 188 x10^3/uL, which is slightly below the laboratory reference range of 195-624 x10^3/uL. This indicates mild thrombocytopenia. Given the patient's age and chronic kidney disease history, this finding may be significant. The slight decrease in platelet count could be due to various factors, including bone marrow suppression, increased destruction, or sequestration in the spleen. However, the deviation from the reference range is not severe.
Thrombocytopenia in cats can be associated with several conditions, including immune-mediated diseases, infections, and bone marrow disorders. In this patient, the concurrent findings of elevated creatinine at 2.6 mg/dL and BUN at 44 mg/dL suggest renal involvement, which could contribute to platelet dysfunction or decreased production. The low potassium level at 3.4 mEq/L and anemia, indicated by a low hematocrit of 29%, may also be related to the underlying renal disease. The elevated liver enzymes, such as ALT at 165 U/L and GGT at 4 U/L, could suggest concurrent hepatic involvement, which can also affect platelet production and function.
If the mild thrombocytopenia remains unaddressed, it could potentially lead to an increased risk of bleeding, especially if the platelet count continues to decline. However, given the current mild nature of the thrombocytopenia, the immediate risk is low. If the underlying cause, such as renal or hepatic dysfunction, is identified and managed appropriately, the platelet count may stabilize or improve. For this cat, addressing the chronic kidney disease and monitoring liver function could help mitigate further decline in platelet count and improve overall prognosis. Maintaining platelet levels within the normal range is crucial for preventing bleeding complications and ensuring the long-term health of this senior cat.
Reticulocytes are immature red blood cells that play a crucial role in the body's ability to respond to anemia or blood loss by increasing red blood cell production. In cats, the reticulocyte count helps assess the bone marrow's response to the need for more red blood cells, which can be vital in understanding various health conditions, especially those affecting oxygen transport and overall vitality. Monitoring reticulocyte levels can provide insights into the cat's regenerative capacity in response to stressors or underlying diseases.
Hyperthyroidism
The combination of marked weight loss (from 4.1 kg to 3.4 kg), polyuria–polydipsia, intermittent vomiting, dull coat and concurrent increases in ALT 165 U/L, ALP 68 U/L and GGT 4 U/L is a classic constellation for feline hyperthyroidism. Cats with hyperthyroidism often show mild azotemia (creatinine 2.6 mg/dL, BUN 44 mg/dL) because excess thyroxine elevates glomerular filtration and masks renal decline.
Progression of chronic kidney disease to IRIS stage 2–3 with secondary renal anemia
Creatinine 2.6 mg/dL, BUN 44 mg/dL and phosphate 6.9 mg/dL exceed IRIS stage 2 thresholds, while HCT 29 % and reticulocytes 0.1 % indicate a non-regenerative anemia typical of chronic kidney disease. The documented history of IRIS stage 1 disease and present hypokalemia at 3.4 mEq/L strengthen this possibility.
Cholangiohepatitis or early hepatic lipidosis
ALT 165 U/L, ALP 68 U/L, GGT 4 U/L and total bilirubin 0.2 mg/dL are all above the feline reference ranges, and even a mild ALP rise is clinically significant in cats. Poor appetite and weekly vomiting could reflect hepatobiliary inflammation or lipid accumulation in the liver secondary to reduced caloric intake.
Chronic inflammatory or neoplastic process (small-cell gastrointestinal lymphoma or FIP)
Marked hyperglobulinemia at 5.2 g/dL with hypoalbuminemia at 3.1 g/dL suggests chronic antigenic stimulation or monoclonal gammopathy. While this pattern can arise in inflammatory bowel disease or neoplasia, the absence of profound leukocytosis or severe hypoalbuminemia keeps this below the top differentials.
| 🔴 | Blood | Requires veterinary consultation | Total protein, HCT, RBC, Haemoglobin, Platelets |
| 🔴 | Liver | Requires veterinary consultation | ALT, ALP, GGT, Total bilirubin, Albumin |
| 🔴 | Kidneys | Requires veterinary consultation | Creatinine, BUN |
| 🔴 | Electrolytes | Requires veterinary consultation | Phosphate, Potassium |
| 🟢 | Metabolism | Within normal range | |
| 🟢 | Pancreas | Within normal range | |
| 🔴 | Immune System | Requires veterinary consultation | Globulin |
The overall status of this panel is urgent. Concurrent azotemia (creatinine 2.6 mg/dL), hyperphosphatemia (6.9 mg/dL) and progressive weight loss call for veterinary assessment within the next few days, not weeks, to prevent further renal injury and address the possible endocrine or hepatic comorbidity evident from ALT 165 U/L and ALP 68 U/L.
This 13-year-old spayed female European Shorthair sits squarely in the senior life-stage defined by the 2021 AAFP/AAHA Feline Life Stage Guidelines, a period when hyperthyroidism, chronic kidney disease and gastrointestinal lymphoma become increasingly prevalent — the so-called senior cat triad. Her chronic oxalate urolithiasis history predisposes her kidneys to additional tubular damage, heightening the risk that today’s creatinine 2.6 mg/dL reflects true nephron loss rather than transient pre-renal change. Hyperphosphatemia at 6.9 mg/dL accelerates secondary renal hyperparathyroidism and soft-tissue mineralization, both of which impair longevity according to IRIS 2023 outcome data. Concurrent hypokalemia (3.4 mEq/L) can worsen muscle weakness and renal tubular acidosis, compounding the vicious cycle of renal decline. The mild but definite elevations in ALT, ALP and GGT are significant in cats because ALP’s short half-life means even small increases flag hepatobiliary stress. Weight loss, decreased activity and hyperglobulinemia (5.2 g/dL) raise the long-term specter of chronic inflammatory diseases such as small-cell lymphoma, which has breed-agnostic but age-related incidence. Finally, the platelet count of 188 ×10^3/µL, though only slightly low, nudges bleeding risk upward during any invasive procedure and should be factored into future diagnostic planning.
The laboratory changes help explain why your cat is drinking bowls of water and making larger clumps in the litter tray. Elevated creatinine 2.6 mg/dL and BUN 44 mg/dL mean her kidneys are not filtering waste as efficiently as they once did, so her body drives thirst to flush out toxins. Excess phosphorus at 6.9 mg/dL can make her feel nauseated, which likely contributes to the weekly vomiting and reduced appetite you notice. Low potassium 3.4 mEq/L and a red-cell count that has slipped to 6.4 ×10^6/µL may leave her feeling weak and less inclined to jump onto the windowsill. The bad breath you smell is partly uremic waste and partly possible liver metabolites because ALT 165 U/L and ALP 68 U/L show that her liver is working harder than normal. All these factors together sap her energy, dull her coat and encourage her to sleep more. Addressing these biochemical imbalances can markedly improve how she feels from day to day.
No prescription drugs are currently in use, but the petroleum-based hairball paste given twice weekly can interfere with fat-soluble vitamin absorption and might exacerbate the mild hypoalbuminemia (3.1 g/dL) by reducing dietary protein utilization. Occasional vomiting after paste administration could mask progression of renal uremia. The senior wet diet is generally kidney-friendly, yet if it is not explicitly phosphorus-restricted, it may be contributing to the phosphorus level of 6.9 mg/dL. Decreased appetite diminishes overall caloric intake, encouraging metabolic fat mobilization that stresses the liver, mirrored by the ALT and ALP rises.
Scenario 1 — Prompt nutritional modification: If a phosphorus-restricted renal therapeutic diet (≤0.6 % phosphorus on a dry-matter basis) replaces the current wet food within the next week, phosphorus could drop below the 5.5 mg/dL target and nausea may lessen, encouraging better food intake. Improved appetite would help stabilize body weight and reduce the risk of hepatic lipidosis. Scenario 2 — Deferred intervention: Should dietary change and phosphate binders be postponed for two months, phosphorus is likely to climb further, potentially above 7.5 mg/dL. According to IRIS data, each 1 mg/dL rise above 6 mg/dL shortens median survival by several months. Continued hypokalemia could progress to muscle weakness, making stair climbing and grooming increasingly difficult, and anemia could deepen, requiring more aggressive treatment later.
Provide multiple wide, low-sided water bowls in addition to the fountain to support high fluid turnover driven by creatinine 2.6 mg/dL and prevent dehydration. Elevate feeding and resting areas onto gentle ramps or steps so the cat can access favorite perches without leaping, mitigating weakness linked to hypokalemia 3.4 mEq/L and anemia. Introduce interactive but low-impact play sessions (wand toys, food puzzles) for 5–10 minutes twice daily; mild exercise can stimulate appetite and maintain muscle mass without stressing compromised kidneys. Finally, schedule and adhere to quiet, predictable routines for feeding, medication and litter changes to reduce stress, as stress can worsen hepatic enzyme elevations and suppress appetite.
An option your veterinarian might discuss is aluminum hydroxide powder (phosphate binder) at 30–45 mg/kg mixed with meals to bind dietary phosphorus and help lower the 6.9 mg/dL level. Potassium gluconate oral liquid (2 mEq/ml) at 0.5 mEq/kg twice daily can correct the 3.4 mEq/L potassium and improve muscle strength. Omega-3 fatty acids (eicosapentaenoic and docosahexaenoic acids) at a combined 50–80 mg/kg/day from fish-oil capsules may dampen renal inflammation and lower ALT. A renal-specific B-complex supplement rich in cobalamin and folate supports red-cell production, countering the HCT of 29 % without overloading protein. Discuss each with your veterinarian to tailor doses and monitor lab values.
PHASE 1 — DIAGNOSTIC / STABILISATION (Days 1–14): Feed a recovery-style canned diet formulated for cats (approximately 75 kcal per 100 g) in four 45 g meals per day to distribute protein and ease nausea. Choose formulas under 0.8 % phosphorus (DM) and moderate protein (~28 % DM) until diagnostic work-up clarifies needs. Avoid high-fat treats and temporarily discontinue hairball paste. Offer 3–5 ml of water via syringe after meals to support hydration. PHASE 2 — TREATMENT SUPPORT (Weeks 3–8 or until re-test confirms improvement): Transition over one week to a therapeutic renal diet canned formula at roughly 180 kcal/day total (split into three 60 g meals) plus a dry renal kibble portion of 10 g at night if additional calories are needed. Mix aluminum hydroxide binder into each wet portion. Time potassium gluconate 30 minutes after meals to optimize absorption. If methimazole is prescribed for hyperthyroidism, give food 2 hours apart from the drug to avoid chelation with binders. Add 1 ml fish-oil emulsion to the evening meal. PHASE 3 — LONG-TERM MAINTENANCE (After normalisation of key parameters): Maintain a renal therapeutic canned diet as 80 % of calories, supplement with 20 % high-quality protein toppers (e.g. cooked turkey breast) to sustain lean mass if BUN remains below 40 mg/dL. Adjust binder dose based on monthly serum phosphorus. Encourage water intake by offering flavored ice cubes (tuna water diluted 1:4). Weigh the cat weekly; a loss of more than 200 g in a month signals diet re-evaluation. Monitor stool consistency and vomiting frequency, reporting any increase to the veterinarian promptly.
Total thyroxine (TT4) is pivotal because hyperthyroidism could explain weight loss, ALT 165 U/L and ALP 68 U/L and would alter renal staging once treated. A complete urinalysis with urine specific gravity and UPC will determine concentrating ability and quantify protein loss, important since creatinine is 2.6 mg/dL and globulin 5.2 g/dL. SDMA testing identifies early renal dysfunction that creatinine may underestimate in muscle-wasted seniors. Abdominal ultrasound evaluates kidney architecture, liver echogenicity and intestinal wall thickness, helping differentiate cholangiohepatitis from lymphoma given the elevated GGT 4 U/L and globulin 5.2 g/dL. Serum bile acids, both pre- and post-prandial, assess functional hepatic reserve where ALT and ALP are abnormal. Finally, indirect blood pressure measurement is advised because hypertension often accompanies both CKD and hyperthyroidism and can worsen the retinal and renal damage silently.
Creatinine is above the reference range at 2.6 mg/dL. This waste product normally leaves the body through the kidneys; when it climbs, it signals reduced filtration. An option your veterinarian might discuss is an angiotensin-converting-enzyme inhibitor such as benazepril, which dilates the efferent glomerular arteriole and can slow protein-driven kidney scarring. BUN is also elevated at 44 mg/dL. Dietary management forms the cornerstone here: therapeutic renal diets reduce nitrogenous waste and contain targeted amino acid profiles that minimize further BUN rise without inducing protein malnutrition. Phosphate sits high at 6.9 mg/dL. Untreated, this mineral accelerates renal secondary hyperparathyroidism and bone demineralization. Phosphate binders like aluminum hydroxide or lanthanum carbonate work by binding dietary phosphorus within the gut so it is excreted in feces instead of absorbed. Potassium is low at 3.4 mEq/L. Chronic kidney disease often causes potassium wasting; oral potassium gluconate replenishes intracellular stores, normalizes neuromuscular function and can improve appetite. ALT is 165 U/L, higher than the feline upper limit, indicating leakage from hepatocytes. Ursodeoxycholic acid is a hydrophilic bile acid that can stabilize cell membranes and improve bile flow; your veterinarian may consider it if cholangiohepatitis is confirmed. ALP 68 U/L and GGT 4 U/L point toward biliary involvement. Antibiotics targeting gram-negative enteric organisms, most commonly amoxicillin–clavulanate, are sometimes employed because ascending bacterial infection is a known trigger for feline cholangitis. Total protein is 8.9 g/dL with globulins 5.2 g/dL. A polyclonal gammopathy from chronic inflammation may respond to corticosteroid-sparing immunomodulators such as chlorambucil, though this is only started after definitive diagnosis. HCT of 29 % reflects a mild, likely renal, non-regenerative anemia. Recombinant feline erythropoietin analogues stimulate bone marrow to produce red cells when endogenous erythropoietin falls, but they require close monitoring for antibody formation. Finally, the platelet count of 188 ×10^3/µL, while only slightly low, means any medication that can interfere with clotting (e.g., non-steroidal anti-inflammatory drugs) must be chosen with caution.
The following peer-reviewed and institutional resources form the scientific basis for veterinary laboratory medicine and the reference standards used in this report:
Links open external websites. Always consult a licensed veterinarian for all clinical decisions.